GESTIÓN EN SALUD PÚBLICA: Compounding Certain Ibuprofen Oral Suspension Products Under Section 503B of the Federal Food, Drug, and Cosmetic Act | FDA

viernes, 10 de febrero de 2023

Compounding Certain Ibuprofen Oral Suspension Products Under Section 503B of the Federal Food, Drug, and Cosmetic Act | FDA

Compounding Certain Ibuprofen Oral Suspension Products Under Section 503B of the Federal Food, Drug, and Cosmetic Act | FDA

No hay comentarios:

Publicar un comentario

Suscribirse a: Enviar comentarios (Atom)